Skip to content

eyeMax Insight Cholangioscopy for Unexplained Bile Duct Stenosis

A Prospective, Multicenter Clinical Study on the Diagnostic Value of eyeMax Insight Cholangioscopy for Unexplained Bile Duct Stenosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05905744
Enrollment
157
Registered
2023-06-15
Start date
2023-06-30
Completion date
2024-07-31
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Stenosis

Brief summary

When clinical doctors cannot diagnose the cause of biliary stricture after comprehensive laboratory and imaging examinations, it is collectively referred to as unexplained bile duct stenosis. This study intends to analyze the diagnostic value of the biliary endoscopy system for unknown cause biliary strictures , and compare the diagnostic efficacy of biopsy under biliary endoscopy guidance with brushing cytology under ERCP.

Detailed description

When clinical doctors cannot diagnose the cause of biliary stricture after comprehensive laboratory and imaging examinations, it is collectively referred to as unexplained bile duct stenosis. This study intends to analyze the diagnostic value of the biliary endoscopy system for unknown cause biliary strictures , and compare the diagnostic efficacy of biopsy under biliary endoscopy guidance with brushing cytology under ERCP. The etiology of biliary strictures is complex, including not only malignant tumors , but also factors such as stones, inflammatory strictures, congenital variations and so on. Currently, the main methods for diagnosing malignant biliary obstruction in clinical practice include clinical examinations, biochemical testing (such as serum CA19-9), imaging, and endoscopic retrograde cholangiopancreatography (ERCP). However, these methods have limitations, such as the limited specificity and sensitivity of CA19-9 and the indirect imaging of ERCP after contrast agent filling. Therefore, these methods are relatively difficult to distinguish the benign and malignant nature of biliary lesions. This study intends to analyze the diagnostic value of the biliary endoscopy system for these unexplained bile duct stenosis.

Interventions

DIAGNOSTIC_TESTcholangioscopy

cholangioscopy examination and forceps biopsy, followed by brush biopsy from ERCP

Sponsors

Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University
CollaboratorUNKNOWN
Zhejiang University
CollaboratorOTHER
The First Affiliated Hospital of Nanchang University
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
LanZhou University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Peking University Cancer Hospital & Institute
CollaboratorOTHER
First Hospital of China Medical University
CollaboratorOTHER
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CollaboratorOTHER
The Second Affiliated Hospital of Baotou Medical College
CollaboratorOTHER
Shandong Province Third hospital
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Unexplained bile duct strictures (cannot be clearly diagnosed by CT, MRI or other imaging methods);

Exclusion criteria

* Patients with cardiac dysfunction, acute pancreatitis, active viral hepatitis; * Patients with mental illness; ③ Previously underwent choledochoscopy examination; ④ Malignant biliary obstruction;

Design outcomes

Primary

MeasureTime frameDescription
positive rate of visual diagnosis of cholangioscopy for unexplained bile duct stenosis1 yearsThe results are compared with pathological results of surgical specimens
positive rate of cholangioscopy-guided forceps biopsy1 yearsThe results are compared with pathological results of surgical specimens

Secondary

MeasureTime frameDescription
adverse event rate of each individual technique1 yearsrecord any adverse events related to the procedure
the positive rate of biopsy1 yearscholangioscopy-guided forceps biopsy, ERCP-guided brush biopsy

Contacts

Primary ContactZhendong Jin, Doctor
Zhendjin@126.com13901618837
Backup ContactYunfeng Wang, Doctor
Fanhuiever@163.com13651663501

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026